This page contains a Flash digital edition of a book.

Membership Committee Attends National Rx Drug Abuse Summit

DATIA is always on the move for its members! DATIA is happy to bring you its newest section of focus: DATIA in Motion. In this section, you will find out what DATIA’s committees are up to. Expect an update from one committee in each edition of DATIA focus.

16,500—Number of individuals that die from prescription drug abuse each year

$70 BILLION—Cost of prescription drug abuse to U.S. economy

125,000—Number of Americans who have died from an opioid related drug overdose

professionals in the pharmaceutical and pub- lic health and safety industries—met in cen- tral Florida to kick off the National Rx Drug Abuse Summit. Te atendees represented 49 states and 2 countries. Elaine Taule, member of the DATIA Board of Directors and Chair of the Communications Commitee, and Phil Dubois, Chairman Elect of the DATIA Board of Directors represented DATIA at the summit. Also present were concerned DATIA Members Dr. Len Abbot, the Direc- tor Science and Technology—Prescription Drug Monitoring for Quest Diagnostics and Dr. Anthony Costantino, President and CEO of DrugScan. Te National Rx Drug Abuse Summit


had its fair share of dignitaries. Dr. Robert DuPont, a Clinical Professor of Psychia- try at Georgetown University School of Medicine and the second Drug Czar under President Nixon and President Ford, served as a moderator. Mayor Michael Bloomberg of New York, Congressman Hal Rogers (Chair of Appropriations of the U.S. House of Representatives), Congress- man Michael Grimm (Member of Financial Services of the U.S. House of Representa- tives), Congressman Bill Keating (Member of Homeland Security and the Foreign Affairs Commitee of the U.S. House of Representatives), Congressman Dan Webster (Member of the Rules Commitee of the U.S. House of Representatives) and

58 datia focus

his year, nearly 900 leading experts on the prescription drug epidemic— from elected and appointed leaders to

Director Gil Kerlikowske (of the White House Office of National Drug Control Policy (ONDCP)) all shared their ideas on how to address the national prescription drug abuse epidemic. Tey were joined by Dr. Margaret Hamburg, Commissioner of the Food and Drug Administration (FDA), Dr. Tomas Frieden, the Director of the Center for Disease Contrrol (CDC), Dr. Nora Volkow, the Director of the National Institute on Drug Abuse (NIDA), Frances Harding, the Director of the Center for Substance Abuse Prevention (CSAP) and Josep Rannazzisi, Deputy Assistant Administrator in the Office of Diversion Control of the U.S. Drug Enforcement Agency (DEA) who all shared that with government and grassroots efforts from concerned citizens this “national epidemic” can be addressed and reversed. Pam Bondi, the Atorney General for the

state of Florida, shared her success on how government leaders, law enforcement and grassroots efforts can reverse the tide of this epidemic. When she first took office, seven people per day were dying as a result of prescription drug abuse. Under her leadership, Florida has made great strides in fighting the prescription drug abuse problem. In 2009, 98 of the top 100-oxy- codone prescription writers resided in Florida. Today, none of the top 100-oxy- codone prescribers reside in the state of Florida. Additionally, for the first time in a decade, the daily death toll for prescription drug abuse deaths per day has declined. But not nearly enough! Karen Kelly, the CEO of Operation UNITE (Unlawful Narcotics Investiga- tions, Treatment and Education), is the force behind the grassroots efforts of this initiative. In 2003 she was called on by Congressman Hal Rogers (KY-5) to create Operation UNITE and has served as the

summer 2013

Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66